Potent Phosphatidylinositol 3-Kinase Inhibitors and Their Biology

Author(s): Mukesh Chandra Joshi, Krishan Kumar, Vikrant Kumar

Journal Name: Current Drug Discovery Technologies

Volume 11 , Issue 2 , 2014

Become EABM
Become Reviewer
Call for Editor


The Phosphoinositide 3-kinase (PI3k) is an important regulator of intracellular signalling pathways, like cell proliferation, migration, survival, and angiogenesis upon activation by growth factor or receptors. The PI3k’s pathway is frequently up-regulated in human cancers, thus inhibition of PI3k’s is a promising approach for cancer therapy. Many potent PI3k’s inhibitors have been reported so far and few of them are in clinical trial like GDC-0941, BGT-226, AZD-6482 and others are natural products etc.

Keywords: Clinical trial, glioblastoma cell lines, leukemia and lymphoma cell lines, phosphoinositide 3-kinase, proliferation, tumor inhibitors.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Page: [113 - 126]
Pages: 14
DOI: 10.2174/1570163810666131229130207
Price: $65

Article Metrics

PDF: 37